Systematic review of 31 studies (26 meta-analysed; IPD from 1029 women) in premenopausal breast cancer: higher pre-chemotherapy AMH predicted resumed ovarian function (AUC 0.79-0.83), but no reliable cut-off across assays was found.
Meta-analysisn = 1,029
van Zwol-Janssens et al. AMH as a marker for resumption of ovarian function after chemotherapy: an IPD meta-analysis and systematic review